impact of recession on your business
Bioresorbable Polymers Market

Bioresorbable Polymers Market Size, Share and Segmentation By type (Polylactic acid (PLA), Polyglycolic acid (PGA), Poly(lactic-co-glycolic acid) (PLGA), Polycaprolactone(PCL), Others) By application (Orthopedic devices, Drug delivery, Others), by Regions and Global Forecast 2023-2030

Report Id: SNS/C&M/2133 | June 2022 | Region: Global | 125 Pages

Report Scope & Overview:

Bioresorbable Polymers Market Size was valued at USD 1.32 billion in 2022 and is expected to reach USD 3.16 billion by 2030, and grow at a CAGR of 10.2 % over the forecast period 2023-2030.

Bioresorbable polymers are a new type of material that can be broken down by the body and don't need to be taken out by hand like sutures or the chlorhexidine chip. Bioresorbable materials can be used for a wide range of medical purposes, such as sutures, scaffolds for the coronary and peripheral vascular systems, tissue fixation screws, bone pins and anchors, coatings for drug delivery, microspheres, and surgical meshes and matrices. This group of materials includes polymers, metals, ceramics, glasses, and materials that come from living things, like natural collagen, which can help release and deliver drugs as well as serve a mechanical purpose.

Bioresorbable Polymers Market Revenue 2030

Market Dynamics:


  • Growing demand in biocompatible medical devices

  • Slowing down the growth of the market.


  • Minimally invasive surgeries are becoming more popular.

  • The more expensive cost of biodegradable polymers

  • Biodegradable polymers not being checked for quality


  • The technologies of electrospinning and 3D printing

  • The government has put a lot of money into research and development.


  • Medical devices are governed by strict rules.

  • Lack of people who know about this and are experts in it

Impact of Covid-19:

Almost every part of the world has been affected by the pandemic. The growth of the bioresorbable polymers market has been negative because of problems in the global supply chain and delays in surgeries that were supposed to happen at certain times. This is happening because demand in the medical field has dropped. In terms of value, the bioresorbable polymers market is worth the most in North America.

South Asian countries like India, Bangladesh, and Sri Lanka, as well as Central Asian countries, saw a drop in the number of medical implants they used. This made less people want biodegradable polymers in the area. China has a big share of the bioresorbable polymers market in the APAC region, but the pandemic made things hard for them at first. Millions of people were put in quarantine, which stopped all supply chains that came from China. It has also hurt the people who work there, without whom many ports like Shenzhen and Shanghai would not be able to operate. But after three months of being shut down, the country has shown signs of getting better. In 2021, there will likely be more surgeries and car accidents, which will increase the need for biodegradable polymers. After the mass vaccination drive began in 2021, other developing countries also sped up their work on biodegradable polymers.

Key Players:

Putnam Plastics (US), Evonik Industries AG (Germany), Ashland (US), DURECT CORPORATION (US), REVA Medical, Inc.(US, Poly-Med Inc. (US), Merck KGaA (Germany), KLS Martin (US), Corbion NV (The Netherlands), Koninklijke DSM N.V (The Netherlands), Foster Corporation. (US), Groupe PCAS (France), and other players.

Market Segment:

By Type

  • Polylactic acid (PLA)

    • Poly (l-lactic) acid (PLLA)

    • -Poly-d,l-lactic acid (PDLLA)

  • Polyglycolic acid (PGA)

  • Poly(lactic-co-glycolic acid) (PLGA)

  • Polycaprolactone(PCL)

  • Others

By Application

  • Orthopedic devices
    • Trauma
    • Hip
    • Knee
    • Spine
    • Sports injury
    • Others
  • Drug Delivery
    • Parenteral
    • Oral
    • Others
  • Others

Bioresorbable Polymers Market Segment Pie Chart

Regional Analysis:

The Bioresorbable Polymers Market shows how they are used in North America, Europe, Latin America, Asia-Pacific, the Middle East and Africa, and other important regions.North America is thought to be the best place to live. In recent years, it has had the biggest share of the market because biomedical industries have been buying more of these polymers. This has driven the regional market. The US and Canada are the most important parts of North America. The growth of the market can be traced to the presence of key industrial players in these two countries. The regional market is growing faster because more innovations and advanced technologies are being used to make new biocompatible polymers better in terms of their physical and degrading properties.

Asia-Pacific has seen a lot of growth, and during the forecast period, it will have the highest CAGR. The APAC market is being driven by the growing need for biodegradable polymers in healthcare industries in developing countries. The market demand is likely to be driven by the rise in consumer awareness in the area. China is in first place, followed by India and countries in Southeast Asia. Because the medical and hospital industry is growing so quickly, these areas are growing at a faster rate. Europe's Bioresorbable Polymers Market is growing quickly because bioresorbable polymers are being used more and more in orthopaedics and drug delivery. Germany is thought to be the biggest contributor because there are so many leading players there.


  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

Bioresorbable Polymers Market Report Scope:
Report Attributes Details
Market Size in 2022 US$ 1.32 Billion
Market Size by 2030 US$ 3.16 Billion
CAGR CAGR of 10.2% From 2023 to 2030
Base Year 2022
Forecast Period 2023-2030
Historical Data 2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Type (Polylactic acid (PLA), Poly (l-lactic) acid (PLLA), -Poly-d,l-lactic acid (PDLLA), Polyglycolic acid (PGA), Poly(lactic-co-glycolic acid) (PLGA), Polycaprolactone(PCL), Others)
• By Application (Orthopedic devices, Drug delivery, Others)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Putnam Plastics, Evonik Industries AG, Ashland, DURECT CORPORATION, REVA Medical, Inc., Poly-Med Inc., Merck KGaA, KLS Martin, Corbion NV, Koninklijke DSM N.V, Foster Corporation., Groupe PCAS, and other players.
DRIVERS • Growing demand in biocompatible medical devices
• Slowing down the growth of the market.
Restraints • Minimally invasive surgeries are becoming more popular.
• The more expensive cost of biodegradable polymers
• Biodegradable polymers not being checked for quality

Frequently Asked Questions (FAQ) :

Table of Contents


1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions


2. Research Methodology


3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges


4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World


5. Value Chain Analysis


6. Porter’s 5 forces model


7.  PEST Analysis


8.Bioresorbable Polymers Market Segment, By Type

8.1 Polylactic acid (PLA)

       8.1.1 Poly (l-lactic) acid (PLLA)

       8.2.2 Poly-d,l-lactic acid (PDLLA)

8.2 Polyglycolic acid (PGA)

8.3 Poly(lactic-co-glycolic acid) (PLGA)

8.4 Polycaprolactone(PCL)

8.5 Others


9. Bioresorbable Polymers Market Segment, By Application

9.1 Orthopedic devices

9.1.1 Trauma

9.1.2 Hip

9.1.3 Knee

9.1.4 Spine

9.1.5 Sports injury

9.1.6 Others

9.2 Drug delivery

9.2.1 Parenteral

9.2.2 Oral

9.2.3 Others

9.3 Others


10. Regional Analysis

10.1 Introduction

10.2 North America

10.2.1 USA

10.2.2 Canada

10.2.3 Mexico

10.3 Europe

10.3.1 Germany

10.3.2 UK

10.3.3 France

10.3.4 Italy

10.3.5 Spain

10.3.6 The Netherlands

10.3.7 Rest of Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 South Korea

10.4.3 China

10.4.4 India

10.4.5 Australia

10.4.6 Rest of Asia-Pacific

10.5 The Middle East & Africa

10.5.1 Israel

10.5.2 UAE

10.5.3 South Africa

10.5.4 Rest

10.6 Latin America

10.6.1 Brazil

10.6.2 Argentina

10.6.3 Rest of Latin America


11. Company Profile

11.1 Putnam Plastics (US) 

11.1.1 Financial

11.1.2 Products/ Services Offered

11.1.3 SWOT Analysis

11.1.4 The SNS view

11.2 Evonik Industries AG (Germany)

11.3 Ashland (US)


11.5 REVA Medical, Inc.(US

11.6 Poly-Med Inc. (US)

11.7 Merck KGaA (Germany)

11.8 KLS Martin (US)

11.9 Corbion NV (The Netherlands)

11.10 Koninklijke DSM N.V (The Netherlands)

11.11 Foster Corporation. (US)

10.12 Groupe PCAS (France)


12.Competitive Landscape

12.1 Competitive Benchmark

12.2 Market Share analysis

12.3 Recent Developments


13. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.